Apelin/APJ system: A key therapeutic target for liver disease

Apelin, a new bioactive peptide, was identified as an endogenous ligand for APJ (Angiotensin II receptor-like 1). Apelin and its receptor have an abundant distribution in central nervous system and peripheral tissues, including liver. Apelin/APJ has diverse physiological and pathological effects, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Shuang-Yu, Cui, Binbin, Chen, Wei-Dong, Wang, Yan-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762386/
https://www.ncbi.nlm.nih.gov/pubmed/29340118
http://dx.doi.org/10.18632/oncotarget.22841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762386/
https://www.ncbi.nlm.nih.gov/pubmed/29340118
http://dx.doi.org/10.18632/oncotarget.22841

Ejemplares similares